We are live on ! Find out more
VCYT icon

Veracyte

215 hedge funds and large institutions have $2.91B invested in Veracyte in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 83 increasing their positions, 66 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

26% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 66

0.84% less ownership

Funds ownership: 109.07%108.23% (-0.84%)

9% less funds holding

Funds holding: 235215 (-20)

26% less capital invested

Capital invested by funds: $3.93B → $2.91B (-$1.02B)

35% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 52

39% less call options, than puts

Call options by funds: $847K | Put options by funds: $1.38M

Holders
215
Holders Change
-20
Holders Change %
-8.51%
% of All Funds
3.73%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
34
Increased
83
Reduced
66
Closed
52
Calls
$847K
Puts
$1.38M
Net Calls
-$536K
Net Calls Change
-$12.2M

VCYT Hedge Fund Activity: Q2 2021 in Review

215 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2021, worth a combined $2.91B — down 26% from $3.93B a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of VCYT and 34 opened new positions — a net loss of 18 holders — while 66 trimmed existing stakes and 83 added.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $43.1M. The largest seller was Matrix Capital Management Company, exiting entirely with an estimated $160M sold.

  • 215 institutional investors held Veracyte (VCYT) as of Q2 2021, down from 235 in Q1 2021.
  • Funds reported $2.91B of Veracyte stock for Q2 2021, down 26% quarter-over-quarter.
  • 34 funds opened new Veracyte positions in Q2 2021 and 52 closed out, a net change of -18 holders.
  • The largest Veracyte buyer in Q2 2021 was ArrowMark Colorado Holdings, an estimated $43.1M added.
  • The largest Veracyte seller in Q2 2021 was Matrix Capital Management Company, an estimated $160M sold.

Based on aggregated 13F filings for Q2 2021.